Delivery Order SPE2DB20D3101-SPE2DB24FQWM1
- Not listed
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Estradiol 10 MCG Vaginal Inserts. The $2,468.48 firm fixed-price contract has a completion date of September 7, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,026.60, is a delivery order for the supply of Estradiol 10 mcg vaginal inserts. The award does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
- This federal contract award, valued at $1,859.27, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of Estradiol 10 MCG Vaginal Inserts, a prescription medication used for the treatment of moderate to severe vaginal atrophy due to menopause. The contract has a completion date of November 21, 2024 and is a firm fixed-price agreement. There is no...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,138.85, is for the delivery of Estradiol 10 MCG Vaginal Insrt 18S, a prescription medication. The contract has a completion date of January 16, 2024 and is a Firm Fixed Price Delivery Order. This contract award is not designated as a set-aside contract. AmerisourceBergen...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,283.84 delivery order contract is for the supply of Estradiol 10 MCG Vaginal Insrt 18S, a hormone therapy medication. This award is part of Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $22,496.67, is for the delivery of Estradiol 10 MCG Vaginal Insert, a prescription medication. The contract has an ultimate completion date of January 9, 2025 and is a firm-fixed-price contract. It is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
- This federal contract award is a delivery order with a firm fixed price of $3,271.56 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,567,847,330 units of Estradiol 10 MCG Vaginal Insrt 18S, a hormone treatment medication. The contract has an ultimate completion date of April 9, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside designation on the contract,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Estradiol 10 MCG Vaginal Inserts. The firm-fixed-price delivery order, valued at $1,164.59, has a completion date of November 8, 2023. The contract is not designated as a set-aside and is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Estradiol 10 MCG Vaginal Inserts. The award, valued at $51,063.45, is a Delivery Order issued under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract, a $999,999,999 umbrella contract that provides a wide range of medical commodities to military treatment programs and facilities worldwide. As this is a Delivery Order, it is not associated...
- This federal contract award, valued at $1,611.98, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ESTRADIOL 10 MCG VAGINAL INSRT 8S, a medical product for vaginal health. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of January 17, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there is...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB24FQWM1Delivery Order
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The delivery order is valued at $1,898.73 and covers the supply of Estradiol 10 MCG Vaginal Inserts. The contract has a completion date of December 12, 2023 and is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. In addition, Amerisourcebergen also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 12/11/23 |